$80.26
1.22[1.54%]
At close: Apr 26
$80.26
0[0.00%]
After Hours: 4:20PM EDT
HealthEquity
(NASDAQ:HQY)HealthEquity Stock (NASDAQ:HQY), Analyst Ratings, Price Targets, Predictions
HealthEquity Inc has a consensus price target of $91.89, established from looking at the 55 latest analyst ratings. The last 3 analyst ratings were released from JMP Securities, JP Morgan, and Keybanc on April 4, 2024, April 2, 2024, and March 22, 2024. With an average price target of $101.33 between JMP Securities, JP Morgan, and Keybanc, there's an implied 26.26% upside for HealthEquity Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
JMP Securities
JP Morgan
Keybanc
Barrington Research
BTIG
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for HealthEquity
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/04/2024 | HQY | Buy Now | HealthEquity | $80.26 | 25.84% | JMP Securities | Constantine Davides | → $101 | Initiates | → Market Outperform | Get Alert |
| 04/02/2024 | HQY | Buy Now | HealthEquity | $80.26 | 34.56% | JP Morgan | Anne Samuel | $86 → $108 | Maintains | Overweight | Get Alert |
| 03/22/2024 | HQY | Buy Now | HealthEquity | $80.26 | 18.37% | Keybanc | Scott Schoenhaus | $85 → $95 | Maintains | Overweight | Get Alert |
| 03/22/2024 | HQY | Buy Now | HealthEquity | $80.26 | 24.6% | Barrington Research | Alexander Paris | → $100 | Maintains | Outperform | Get Alert |
| 03/20/2024 | HQY | Buy Now | HealthEquity | $80.26 | 37.05% | BTIG | David Larsen | $100 → $110 | Maintains | Buy | Get Alert |
| 03/20/2024 | HQY | Buy Now | HealthEquity | $80.26 | 14.63% | RBC Capital | Sean Dodge | $90 → $92 | Maintains | Outperform | Get Alert |
| 03/20/2024 | HQY | Buy Now | HealthEquity | $80.26 | 20.86% | B of A Securities | Allen Lutz | $93 → $97 | Maintains | Buy | Get Alert |
| 02/23/2024 | HQY | Buy Now | HealthEquity | $80.26 | 12.14% | RBC Capital | Sean Dodge | $77 → $90 | Maintains | Outperform | Get Alert |
| 02/23/2024 | HQY | Buy Now | HealthEquity | $80.26 | 29.58% | Barclays | — | $84 → $104 | Maintains | Overweight | Get Alert |
| 12/13/2023 | HQY | Buy Now | HealthEquity | $80.26 | 18.37% | Raymond James | C. Gregory Peters | $90 → $95 | Maintains | Outperform | Get Alert |
| 12/06/2023 | HQY | Buy Now | HealthEquity | $80.26 | 15.87% | Wells Fargo | Stan Berenshteyn | $89 → $93 | Maintains | Overweight | Get Alert |
| 12/04/2023 | HQY | Buy Now | HealthEquity | $80.26 | 5.91% | Barrington Research | Alexander Paris | → $85 | Reiterates | Outperform → Outperform | Get Alert |
| 12/01/2023 | HQY | Buy Now | HealthEquity | $80.26 | -9.05% | JP Morgan | Anne Samuel | $81 → $73 | Maintains | Overweight | Get Alert |
| 09/21/2023 | HQY | Buy Now | HealthEquity | $80.26 | 8.4% | Baird | Mark Marcon | $79 → $87 | Upgrade | Neutral → Outperform | Get Alert |
| 09/07/2023 | HQY | Buy Now | HealthEquity | $80.26 | -10.29% | Deutsche Bank | George Hill | $71 → $72 | Maintains | Buy | Get Alert |
| 09/06/2023 | HQY | Buy Now | HealthEquity | $80.26 | 5.91% | Barrington Research | Alexander Paris | $80 → $85 | Reiterates | Outperform → Outperform | Get Alert |
| 09/06/2023 | HQY | Buy Now | HealthEquity | $80.26 | -4.06% | RBC Capital | Sean Dodge | $75 → $77 | Maintains | Outperform | Get Alert |
| 06/07/2023 | HQY | Buy Now | HealthEquity | $80.26 | -11.54% | Deutsche Bank | George Hill | $69 → $71 | Maintains | Buy | Get Alert |
| 06/06/2023 | HQY | Buy Now | HealthEquity | $80.26 | -6.55% | RBC Capital | Sean Dodge | → $75 | Reiterates | → Outperform | Get Alert |
FAQ
What is the target price for HealthEquity (HQY)?
The latest price target for HealthEquity (NASDAQ: HQY) was reported by JMP Securities on April 4, 2024. The analyst firm set a price target for $101.00 expecting HQY to rise to within 12 months (a possible 25.84% upside). 20 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for HealthEquity (HQY)?
The latest analyst rating for HealthEquity (NASDAQ: HQY) was provided by JMP Securities, and HealthEquity initiated their market outperform rating.
When was the last upgrade for HealthEquity (HQY)?
The last upgrade for HealthEquity Inc happened on September 21, 2023 when Baird raised their price target to $87. Baird previously had a neutral for HealthEquity Inc.
When was the last downgrade for HealthEquity (HQY)?
The last downgrade for HealthEquity Inc happened on December 7, 2021 when Raymond James changed their price target from $90 to $70 for HealthEquity Inc.
When is the next analyst rating going to be posted or updated for HealthEquity (HQY)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HealthEquity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HealthEquity was filed on April 4, 2024 so you should expect the next rating to be made available sometime around April 4, 2025.
Is the Analyst Rating HealthEquity (HQY) correct?
While ratings are subjective and will change, the latest HealthEquity (HQY) rating was a initiated with a price target of $0.00 to $101.00. The current price HealthEquity (HQY) is trading at is $80.26, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.